Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05367271 · ClinicalTrials.gov registry record · Phase 2
The Efficacy of Botulinum Toxin vs. Corticosteroid for the Treatment of Refractory Plantar Fasciitis
A Phase 2 study, sponsored by Western Institute for Veterans Research.
- Completed
- Registry status
- Phase 2
- Development phase
- 62
- Enrollment target
NCT05367271: Completed Phase 2 study, sponsored by Western Institute for Veterans Research.
NCT05367271 is a Phase 2 study that has completed, run by Western Institute for Veterans Research. The registered enrollment target is 62 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (53% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05367271, a Phase 2 study, has completed, sponsored by Western Institute for Veterans Research.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 62 participants
- Enrollment target
Study Summary
This single-blinded, randomized-controlled trial compares the efficacy of ultrasound-guided onabotulinumtoxinA (BTX-A) injections to the flexor digitorum brevis with current standard of care corticosteroid injections to the plantar fascia for the treatment of refractory plantar fasciitis in patients that have failed six weeks of non-operative treatment.
Primary Outcome
Measured via patient-reported Numeric Pain Rating Scale (NPRS)
Interventions
- DRUG Dexamethasone
- DRUG Botulinum Toxin A
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2022-08-23 |
| Est. Completion | 2024-09-13 |
| Phase | Phase 2 |
What the finished NCT05367271 record still lists
NCT05367271 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 62 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (53% lower).
The record links to 0 conditions, and to 2 interventions - of which Dexamethasone is the first listed.
NCT05367271 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05367271 about?
NCT05367271 is a clinical study titled "The Efficacy of Botulinum Toxin vs. Corticosteroid for the Treatment of Refractory Plantar Fasciitis". This single-blinded, randomized-controlled trial compares the efficacy of ultrasound-guided onabotulinumtoxinA (BTX-A) injections to the flexor digitorum brevis with current standard of care corticosteroid injections to the plantar fascia for the treatment of refractory plantar fasciitis in patients...
What is the current status of trial NCT05367271?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 62 participants. The study started on 2022-08-23. Estimated completion is 2024-09-13.
What interventions are being tested in trial NCT05367271?
The interventions under investigation include: Dexamethasone (DRUG), Botulinum Toxin A (DRUG).
Who is sponsoring clinical trial NCT05367271?
This trial is sponsored by Western Institute for Veterans Research, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05367271's enrollment target sits among peer trials
62 1016th of 2000 higher than 975 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03231150 · 62 participants · NA
Plantar Fasciitis Randomized Clinical Control Trial
- NCT03458676 · 62 participants · NA
Radiologic Pathologic Correlation of Advanced MR Imaging to Guide the Biopsy of Cerebral Malignancies
- NCT03596086 · 62 participants · Phase 1
HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM
- NCT03603405 · 62 participants · Phase 1
HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI